That is the same advice federal and provincial health officials have been giving Canadians since the first vaccines were approved in December. But it is in direct contrast to advice given Monday by the National Advisory Committee on Immunization.
NACI said the mRNA vaccines from Pfizer-BioNTech and Moderna are preferred because they don t carry the remote risk of a new blood-clotting syndrome.
The 16-member panel of doctors and other vaccine experts said that Canadians who aren t at high risk of COVID-19 may choose to turn down the offer of Oxford-AstraZeneca or Johnson & Johnson and wait until they can get an mRNA vaccine.
Analysis: Will Montreal ever achieve herd immunity in the pandemic? montrealgazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from montrealgazette.com Daily Mail and Mail on Sunday newspapers.
Lee Berthiaume
A dose of the Pfizer COVID-19 vaccination is prepared in Montreal, Friday, April 30, 2021. THE CANADIAN PRESS/Ryan Remiorz May 03, 2021 - 1:00 AM
OTTAWA - Canada is set to begin receiving more than 2 million doses of the Pfizer-BioNTech vaccine each week as the two pharmaceutical firms ramp up their deliveries and begin shipping shots from the United States.
Pfizer and BioNTech have been consistently delivering around 1 million doses from Brussels each week since mid-March, but those numbers will double over the next month before increasing further in June.
This week s doses will also be the first to arrive from Pfizer s plant in Kalamazoo, Mich., after the U.S. government previously restricted vaccine exports to inoculate its own citizens.
OTTAWA Canada is set to begin receiving more than 2 million doses of the Pfizer-BioNTech vaccine each week as the two pharmaceutical firms ramp up their deliveries and begin shipping shots from the United States. Pfizer and BioNTech have been consistently delivering around 1 million doses from Brussels each week since mid-March, but those numbers will double over the next month before increasing further in June. This week s doses will also be the first to arrive from Pfizer s plant in Kalamazoo, Mich., after the U.S. government previously restricted vaccine exports to inoculate its own citizens. There was no immediate word, however, on progress in talks with the U.S. over the provision of more doses of the Oxford-AstraZeneca vaccine, which is in high demand across the country.